Inventor · disambiguated record
Bradford H. Hirth
Also filed as: HIRTH BRADFORD · HIRTH BRADFORD H · JANJIGIAN ANDREW
32 granted patents·16 pending applications·429 citations·filing 1994–2025
97Inventor score
Top patents by PatentIndex Score
48 records- 0197US6855830B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2002·Granted Feb 15, 2005·67 cites·2 claims
- 0296US7763738B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2007·Granted Jul 27, 2010·28 cites·5 claims
- 0394US7265228B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2004·Granted Sep 4, 2007·34 cites·16 claims
- 0494US6835831B2Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2002·Granted Dec 28, 2004·34 cites·33 claims
- 0592US11008316B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2017·Granted May 18, 2021·6 cites·2 claims
- 0692US6410533B1Antibacterial compoundsGENZYME CORP·Filed 2000·Granted Jun 25, 2002·52 cites·23 claims
- 0790US9139580B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Granted Sep 22, 2015·14 cites·1 claims
- 0888US8138353B2Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsHIRTH BRADFORD H·Filed 2010·Granted Mar 20, 2012·7 cites·6 claims
- 0987US9126993B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Sep 8, 2015·9 cites·1 claims
- 1087US5466712ASubstituted n-aryl-1,2-diaminocyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1994·Granted Nov 14, 1995·49 cites·20 claims
- 1186US12060349B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Granted Aug 13, 2024·1 cites·7 claims
- 1284US9546161B2Synthesis of UDP-glucose: N-acylsphingosine glucosyl transferase inhibitorsGENZYME CORP·Filed 2014·Granted Jan 17, 2017·3 cites·3 claims
- 1384US8779163B2Synthesis of UDP-Glucose: N-acylsphingosine glucosyl transferase inhibitorsHIRTH BRADFORD H·Filed 2012·Granted Jul 15, 2014·4 cites·3 claims
- 1482US5464867ADiaminocyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1994·Granted Nov 7, 1995·14 cites·27 claims
- 1582US2025026749A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2024·Application pending·0 cites
- 1681US5532245ASubstituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compoundsAMERICAN HOME PROD·Filed 1995·Granted Jul 2, 1996·41 cites·7 claims
- 1780US7041831B2Diastereoselective synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2004·Granted May 9, 2006·7 cites·6 claims
- 1880US6969728B2Modulators of TNF-α signalingGENZYME CORP·Filed 2001·Granted Nov 29, 2005·12 cites·64 claims
- 1978US7034031B2Modulators of TNF-α signalingGENZYME CORP·Filed 2004·Granted Apr 25, 2006·9 cites·19 claims
- 2076US8921547B2Modulators of TNF-α signalingGENZYME CORP·Filed 2013·Granted Dec 30, 2014·2 cites·16 claims
- 2175US2021171507A1Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2020·Application pending·0 cites
- 2272US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 2371US8518999B2Modulators of TNF-αsignalingSNEDDON SCOTT F·Filed 2005·Granted Aug 27, 2013·2 cites·16 claims
- 2471US2019322649A1Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2018·Application pending·0 cites
- 2568US2025197422A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2666US8633168B2Inhibitors of S-adenosyl-L-methionine decarboxylaseXIANG YIBIN·Filed 2008·Granted Jan 21, 2014·1 cites·18 claims
- 2766US5512585ADiaminocyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1995·Granted Apr 30, 1996·7 cites·15 claims
- 2866US2017334888A1Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitorsGENZYME CORP·Filed 2016·Application pending·0 cites
- 2965US2024279220A1Indole compounds and methods of useGENZYME CORP·Filed 2024·Application pending·0 cites
- 3064US9579325B2Modulators of TNF-α signalingGENZYME CORP·Filed 2014·Granted Feb 28, 2017·0 cites·1 claims
- 3164US7541466B2Tetrahydroisoquinoline derivatives for treating protein trafficking diseasesGENZYME CORP·Filed 2004·Granted Jun 2, 2009·1 cites·33 claims
- 3264US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 3364US2024239784A1Indole compounds and methods of useGENZYME CORP·Filed 2024·Application pending·0 cites
- 3457US2015210681A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Application pending·0 cites
- 3555US5763474ASubstituted N-arylmethylamino derivatives of cyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1997·Granted Jun 9, 1998·6 cites·27 claims
- 3654US5530025ADiaminocyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1995·Granted Jun 25, 1996·3 cites·21 claims
- 3753US5536731ADiaminocyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1995·Granted Jul 16, 1996·3 cites·8 claims
- 3853US5536741ADiaminocyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1995·Granted Jul 16, 1996·3 cites·6 claims
- 3953US2016207933A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2015·Application pending·0 cites
- 4049US2025248975A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4149US2025197420A1Macrocyclic compounds, compositions, and methods of using thereofSIONNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4247US5605909ASubstituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compoundsAMERICAN HOME PROD·Filed 1996·Granted Feb 25, 1997·5 cites·5 claims
- 4346US11098056B2UDP glycosyltransferase inhibitors and methods of useGENZYME CORP·Filed 2019·Granted Aug 24, 2021·0 cites·30 claims
- 4445US5780505ASubstituted N-arylmethylamino derivatives of cyclobutene-3, 4-dionesAMERICAN HOME PROD·Filed 1997·Granted Jul 14, 1998·3 cites·35 claims
- 4545US2007015793A1Synthesis of nojirimycinsMACROZYME DNM B V·Filed 2004·Application pending·0 cites
- 4642US2007254894A1Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferationKANE JOHN L JR·Filed 2007·Application pending·0 cites
- 4742US2011275673A1Inhibitors of sphingosine kinase 1XIANG YIBIN·Filed 2009·Application pending·0 cites
- 4841US5846999ASubstituted N-arylmethylamino derivatives of cyclobutene-3,4-dionesAMERICAN HOME PROD·Filed 1997·Granted Dec 8, 1998·2 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →